WT1 and Miyoshi myopathy: IHC characteristics were consistent with MM clinico-pathological features, including diffuse positivity for calretinin (Fig. 1B) and focal positivity for WT1 (Fig. 1C) for mesothelioma, focal positivity for CK5/6 (Fig. 1D), wide positivity for D2-40 (Fig. 1E) for epithelial carcinoma, and negative for MOC31 (Fig. 1F) adenocarcinoma.